XW143F8 Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
Billable / valid for submission ICD10PCS Release FY2026-APR
Description changes on October 1, 2026 in FY2027, to: Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
Short description: Transfuse OTL-103 in Central Vein, Perc, New Tech 8
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | 2026-03-31 | Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8 | yes |
| FY2026-APR | 2026-04-01 | current | Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8 | yes |
Related codes in XW1
- XW1 New Technology, Anatomical Regions, Transfusion
- XW13325 Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
- XW1337A Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
- XW133B8 Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133C8 Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133D7 Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7